Manufacturing

Articles

The UK Stem Cell Bank released validated stem-cell lines for researchers developing novel cell-based therapies for clinical trials.

UKSCB Releases Stem Cell Lines for Development

This three-year partnership will explore and identify new tools and methods to modify and optimize the Chinese hamster ovary (CHO) cell line performance.

Austrian Centre of Industrial Biotechnology and GE Healthcare Form Cell Line Engineering Pact

Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.

Oxford Genetics Receives Grant from Innovate UK

Oxford Genetics has been awarded a grant to develop packaging cell lines for virus bioproduction and will work in collaboration with the University of Oxford to generate cell lines for the scalable manufacture of retrovirus and lentivirus vectors.

Oxford Genetics and University of Oxford Form Virus Production Pact

Oxford Genetics has secured a GBP1 million capital from investment group Mercia Technologies to support its growth strategy in delivering new services for cancer-fighting gene-therapy technologies.

Oxford Genetics Secures GBP1 Million Investment for Gene Therapy Technologies

Horizon announces new bioproduction outlicense deal with an unnamed partner for a minimum value of £500,000.

Horizon Discovery Signs Subscription-Based Licensing Agreement for Biomanufacturing Cell Lines

The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.

Sartorius Stedim Biotech Introduces Fully Integrated Upstream Platform

Probiodrug has signed an agreement with Rentschler Biotechnologie GmbH for the development of PBD-C06, a pGlu-Abeta-specific monoclonal antibody, as treatment for patients with Alzheimer’s disease.

Probiodrug Signs Manufacturing Agreement with Rentschler for Monoclonal Antibody PBD-C06

Aragen Bioscience has licensed ProteoNic Biotechnology’s 2G UNic recombinant protein production technology, which increases manufacturing efficiency and reduces cost of goods for recombinant biologicals.

Aragen Bioscience Licenses Protein Production Technology

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

More biopharma companies choose outside service providers for assay testing.

Manufacturing, Cell-Line Selection